Determination of Etofibrate, Fenofibrate, and Atorvastatin in Pharmaceutical Preparations and Plasma Using Differential Pulse Polarographic and Square Wave Voltammetric TechniquesKORANY, Mohamed A; HEWALA, Ismail I; ABDEL-HAY, Karim M et al.Journal of AOAC International. 2008, Vol 91, Num 5, pp 1051-1058, issn 1060-3271, 8 p.Article

Paradoxical decreases in high-density lipoprotein cholesterol with fenofibrate : a quite common phenomenonMAGEE, G; SHARPE, P. C.Journal of clinical pathology. 2009, Vol 62, Num 3, pp 250-253, issn 0021-9746, 4 p.Article

Thin-layer chromatography-densitometry : Determination of fenofibrate and gemfibrozil in pharmaceuticals by densitometric and videodensitometric thin-layer chromatographyKOMSTA, Łlukasz; MISZTAL, Genowefa.Journal of AOAC International. 2005, Vol 88, Num 5, pp 1517-1524, issn 1060-3271, 8 p.Article

After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study : Implications for FenofibrateSACKS, Frank M.The American journal of cardiology. 2008, Vol 102, Num 12, issn 0002-9149, 34L-40L, SUPArticle

Effectiveness and tolerability of Simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)GRUNDY, Scott M; VEGA, Gloria L; ZHONG YUAN et al.The American journal of cardiology. 2005, Vol 95, Num 4, pp 462-468, issn 0002-9149, 7 p.Article

Fenofibrate-induced photosensitivityLEENUTAPHONG, V; MANUSKIATTI, W.Journal of the American Academy of Dermatology. 1996, Vol 35, Num 5, pp 775-777, issn 0190-9622, 1Article

Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statinJONES, Peter H; DAVIDSON, Michael H.The American journal of cardiology. 2005, Vol 95, Num 1, pp 120-122, issn 0002-9149, 3 p.Article

Inhibitory effect of fenofibrate on neointima hyperplasia via G₀/G₁ arrest of cell proliferationLEE, Jung-Jin; YU, Ji-Yeon; ZHANG, Wei-Yun et al.European journal of pharmacology. 2011, Vol 650, Num 1, pp 342-349, issn 0014-2999, 8 p.Article

Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemiaKWANG KON KOH; QUON, Michael J; SEUNG HWAN HAN et al.Journal of the American College of Cardiology. 2005, Vol 45, Num 10, pp 1649-1653, issn 0735-1097, 5 p.Article

Fenofibrate-induced cirrhosisAHMED, Furqaan; PETROVIC, Lydia; ROSEN, Ellen et al.Digestive diseases and sciences. 2005, Vol 50, Num 2, pp 312-313, issn 0163-2116, 2 p.Article

Fenofibrate administration does not affect muscle triglyceride concentration or insulin sensitivity in humansPERREAULT, Leigh; BERGMAN, Bryan C; HUNERDOSSE, Devon M et al.Metabolism, clinical and experimental. 2011, Vol 60, Num 8, pp 1107-1114, issn 0026-0495, 8 p.Article

Paradoxical Decrease in High-Density Lipoprotein Cholesterol with Fenofibrate: A Ouite Rare Phenomenon IndeedMOMBELLI, Giuliana; PAZZUCCONI, Franco; BONDIOLI, Alighiero et al.Cardiovascular therapeutics (Print). 2010, Vol 28, Num 3, pp 153-160, issn 1755-5914, 8 p.Article

Estimation of atorvastatin calcium and fenofibrate in tablets by derivative spectrophotometry and liquid chromatographyNAKARANI, Naresh V; BHATT, Kashyap K; PATEL, Rutva D et al.Journal of AOAC International. 2007, Vol 90, Num 3, pp 700-705, issn 1060-3271, 6 p.Article

Profile of Serum Bile Acids in Noncholestatic Volunteers: Gender-Related Differences in Response to FenofibrateTROTTIER, J; CARON, P; STRAKA, R. J et al.Clinical pharmacology and therapeutics. 2011, Vol 90, Num 2, pp 279-286, issn 0009-9236, 8 p.Article

Analysis of PPARα-dependent and PPARα-independent transcript regulation following fenofibrate treatment of human endothelial cellsARAKI, Hiromitsu; TAMADA, Yoshinori; TOMIYASU, Yuki et al.Angiogenesis (London). 2009, Vol 12, Num 3, pp 221-229, issn 0969-6970, 9 p.Article

Rhabdomyolyse induite par le fénofibrate en monothérapie = Rhabdomyolysis induced by fenofibrate monotherapyARCHAMBEAUD-MOUVEROUX, F; LOPEZ, S; COMBES, C et al.La Revue de médecine interne (Paris). 2006, Vol 27, Num 7, pp 573-574, issn 0248-8663, 2 p.Article

Fabrication of a uniformly sized fenofibrate microemulsion by membrane emulsificationPRADHAN, Roshan; DONG WON LEE; CHOI, Han-Gon et al.Journal of microencapsulation. 2013, Vol 30, Num 1, pp 42-48, issn 0265-2048, 7 p.Article

Fenofibrate ― A Potential Systemic Treatment for Diabetic Retinopathy?TIEN YIN WONG; SIMO, Rafael; MITCHELL, Paul et al.American journal of ophthalmology. 2012, Vol 154, Num 1, pp 6-12, issn 0002-9394, 7 p.Article

Gynecomastia associated with fenofibrateGARDETTE, Virginie; VEZZOSI, Delphine; MAIZA, Jean-Christophe et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 3, pp 508-511, issn 1060-0280, 4 p.Article

Simultaneously measuring concentrations of a model drug and a model excipient in solution using ultrasonic spectrometryCHEN, Raymond R; ZELESKY, Todd; ILASI, Nicholas et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 2, pp 239-247, issn 0731-7085, 9 p.Article

A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet NetworkASLIBEKYAN, Stella; KABAGAMBE, Edmond K; ORDOVAS, Jose M et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 3, pp 191-197, issn 1744-6872, 7 p.Article

Apolipoprotein *B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: Effect of fenofibrate treatmentCHAN, Dick C; WONG, Annette T. Y; YAMASHITA, S et al.Atherosclerosis. 2012, Vol 221, Num 2, pp 484-489, issn 0021-9150, 6 p.Article

Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcriptsRASOULI, Neda; KERN, Philip A; ELBEIN, Steven C et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 7, pp 484-497, issn 1744-6872, 14 p.Article

Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemiaLEE, Sang-Hak; CHO, Kyoung-Im; CHOI, Dong-Ju et al.Atherosclerosis. 2012, Vol 221, Num 1, pp 169-175, issn 0021-9150, 7 p.Article

PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic ratsRODRIGUEZ-VILARRUPLA, Aina; LAVINA, Bàrbara; GARCIA-CALDERO, Hector et al.Journal of hepatology. 2012, Vol 56, Num 5, pp 1033-1039, issn 0168-8278, 7 p.Article